|
|
||||||||||||||
|
|
|||||||||||||||
a Department of Otorhinolaryngology, Hirosaki University School of Medicine, 5 Zaifu-cho, Hirosaki 036-8562, Japan, b Department of Otorhinolaryngology, Tokyo Kosei Nenkin Hospital, Tokyo 162, Japan, c Department of Otorhinolaryngology, Hamamatsu University School of Medicine, Hamamatsu 431-31, Japan, d Department of Otolaryngology, Otsu Red Cross Hospital, Otsu 520, Japan, e Department of Otolaryngology, Osaka University Faculty of Medicine, Suita 565-0871, Japan, f Department of Otorhinolaryngology, Faculty of Medicine, Kyushu University, Fukuoka 812-8582, Japan, g Department of Otorhinolaryngology, Miyazaki Medical College, Miyazaki 889-16, Japan
Correspondence to: Professor Usami, Department of Otorhinolaryngology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan
Revised version received 16 August 1999;
Accepted for publication 27 August
1999
The frequency of three mitochondrial point mutations,
1555A
G, 3243A
G, and 7445A
G, known to be associated with
hearing impairment, was examined using restriction fragment length
polymorphism (RFLP) analysis in two Japanese groups: (1) 319 unrelated
SNHL outpatients (including 21 with aminoglycoside antibiotic injection
history), and (2) 140 cochlear implantation patients (including 22 with aminoglycoside induced hearing loss). Approximately 3% of the outpatients and 10% of the cochlear implantation patients had the
1555A
G mutation. The frequency was higher in the patients with a
history of aminoglycoside injection (outpatient group 33%, cochlear
implantation group 59%). One outpatient (0.314%) had the 3243A
G
mutation, but no outpatients had the 7445A
G mutation and neither
were found in the cochlear implantation group. The significance of the
1555A
G mutation, the most prevalent mitochondrial mutation found in
this study of a hearing impaired population in Japan, among subjects
with specific backgrounds, such as aminoglycoside induced hearing loss,
is evident.
This article has been cited by other articles:
![]() |
M. Bitner-Glindzicz and S. Rahman Ototoxicity caused by aminoglycosides BMJ, October 20, 2007; 335(7624): 784 - 785. [Full Text] [PDF] |
||||
![]() |
R. G. Whittaker, A. M. Schaefer, R. McFarland, R. W. Taylor, M. Walker, and D. M. Turnbull Diabetes and Deafness: Is it sufficient to screen for the mitochondrial 3243A>G mutation alone? Diabetes Care, September 1, 2007; 30(9): 2238 - 2239. [Full Text] [PDF] |
||||
![]() |
K. Siemering, S. S.M. Manji, W. M. Hutchison, D. Du Sart, D. Phelan, and H.-H. M. Dahl Detection of Mutations in Genes Associated with Hearing Loss Using a Microarray-Based Approach J. Mol. Diagn., September 1, 2006; 8(4): 483 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.J.A.M. Jacobs, G. de Wert, J.P.M. Geraedts, I.F.M. de Coo, and H.J.M. Smeets The transmission of OXPHOS disease and methods to prevent this Hum. Reprod. Update, March 1, 2006; 12(2): 119 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Li, J H Greinwald Jr, L Yang, D I Choo, R J Wenstrup, and M-X Guan Molecular analysis of the mitochondrial 12S rRNA and tRNASer(UCN) genes in paediatric subjects with non-syndromic hearing loss J. Med. Genet., August 1, 2004; 41(8): 615 - 620. [Full Text] [PDF] |
||||
![]() |
F J del Castillo, M Rodriguez-Ballesteros, Y Martin, B Arellano, J Gallo-Teran, C Morales-Angulo, R Ramirez-Camacho, M Cruz Tapia, J Solanellas, A Martinez-Conde, et al. Heteroplasmy for the 1555A>G mutation in the mitochondrial 12S rRNA gene in six Spanish families with non-syndromic hearing loss J. Med. Genet., August 1, 2003; 40(8): 632 - 636. [Full Text] |
||||
![]() |
F J del Castillo, M Villamar, M A Moreno-Pelayo, J J Almela, C Morera, I Adiego, F Moreno, and I del Castillo Maternally inherited non-syndromic hearing impairment in a Spanish family with the 7510T>C mutation in the mitochondrial tRNASer(UCN) gene J. Med. Genet., December 1, 2002; 39(12): e82 - 82. [Full Text] [PDF] |
||||
![]() |
M. Bitner-Glindzicz Hereditary deafness and phenotyping in humans Br. Med. Bull., October 1, 2002; 63(1): 73 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Spellberg, R. M. Carroll, E. Robinson, and E. Brass mtDNA Disease in the Primary Care Setting Arch Intern Med, November 12, 2001; 161(20): 2497 - 2500. [Abstract] [Full Text] [PDF] |
||||
![]() |
T P Hutchin, K R Thompson, M Parker, V Newton, M Bitner-Glindzicz, and R F Mueller Prevalence of mitochondrial DNA mutations in childhood/congenital onset non-syndromal sensorineural hearing impairment J. Med. Genet., April 1, 2001; 38(4): 229 - 231. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |